Literature DB >> 6372459

Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk for infection.

H C Neu.   

Abstract

The mechanisms of resistance encountered in bacteria causing infection in the patient at risk for infection are diverse. Most resistance currently seen is the result of plasmid transfer rather than mutational events. However, extensive use of antimicrobial agents in the hospital has caused the selection of organisms resistant to many agents by virtue of chromosomally mediated mechanisms. Staphylococcus aureus resistant to beta-lactams due to altered penicillin-binding proteins has become a problem in certain patients such as narcotic addicts and chronic care facility patients exposed to many beta-lactam antibiotics. S. epidermidis has also proved to be a problem in patients with indwelling foreign devices, and altered penicillin-binding proteins also make these organisms resistant to available penicillins and cephalosporins. Streptococcus fecalis has become increasingly resistant to aminoglycosides, erythromycin, and tetracyclines due to plasmid-mediated enzymes. Hemophilus influenzae resistant to both penicillins and chloramphenicol by virtue of beta-lactamases and chloramphenicol transacetylase has been encountered. Beta-lactamase-mediated resistance of Enterobacteriaceae, Escherichia coli, and Klebsiella pneumoniae to beta-lactam antibiotics has increased, and resistance of Serratia marcescens and Pseudomonas aeruginosa to aminoglycosides and penicillins is a widespread phenomenon. Mechanisms to reduce resistance will include not only careful attention to hygienic practices but also more appropriate use of antibiotics selecting the proper agent depending on the type of patient and environment in which the infection develops.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372459     DOI: 10.1016/0002-9343(84)90240-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

2.  Effects of a restrictive antibiotic policy on clinical efficacy of antibiotics and susceptibility patterns of organisms.

Authors:  A W Sturm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

3.  Infectious drug resistance.

Authors:  B A Lewis
Journal:  J Natl Med Assoc       Date:  1985-02       Impact factor: 1.798

Review 4.  Epidemiology, therapy and costs of nosocomial infection.

Authors:  R Gálvez-Vargas; A Bueno-Cavanillas; M García-Martín
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

5.  The use of new broad spectrum antibiotics.

Authors:  F Follath
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

6.  Drug-resistant coagulase-negative skin staphylococci. Evaluation of four marker systems and epidemiology in an orthopaedic ward.

Authors:  M Thore; I Kühn; S Löfdahl; L G Burman
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

Review 7.  Macrolide antibiotics in paediatric infectious diseases.

Authors:  D R Guay
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

8.  Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.

Authors:  N X Chin; K Jules; H C Neu
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

9.  Pasteurized whole milk confers reduced susceptibilities to the antimicrobial agents trimethoprim, gatifloxacin, cefotaxime and tetracycline via the marRAB locus in Escherichia coli.

Authors:  Yang Peng; Ricardo L Hernandez; Robert R Crow; Suzanna E Jones; Sara A Mathews; Ayanna M Arnold; Eliseo F Castillo; Jennifer M Moseley; Manuel F Varela
Journal:  J Dairy Res       Date:  2008-11       Impact factor: 1.904

10.  Study on pathogenesis of Enterococcus faecalis in urinary tract.

Authors:  T Hirose; Y Kumamoto; N Tanaka; M Yoshioka; T Tsukamoto
Journal:  Urol Res       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.